International Biotechnology Trust PLC Avadel Pharmaceuticals PLC Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
Shares
2 transactions
Others Institutions Holding AVDL
# of Institutions
6Shares Held
738KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL600KShares$5.05 Million4.07% of portfolio
-
Schulhoff & CO Inc137KShares$1.15 Million0.67% of portfolio
-
American Portfolios Advisors Holbrook, NY500Shares$4,2050.0% of portfolio
-
American Research & Management Co.100Shares$8410.0% of portfolio
-
Exane Derivatives33Shares$2770.0% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $509M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...